Chemotherapy of Hodgkin's lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study (Q44628946)
Jump to navigation
Jump to search
scientific article published in January 1989
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Chemotherapy of Hodgkin's lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study |
scientific article published in January 1989 |
Statements
1 reference
Chemotherapy of Hodgkin's lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study (English)
1 reference
V Diehl
1 reference
M Pfreundschuh
1 reference
M Löffler
1 reference
U Rühl
1 reference
E Hiller
1 reference
H Gerhartz
1 reference
W Wilmanns
1 reference
H Kirchner
1 reference
W Schoppe
1 reference
S Petsch
1 reference
1 January 1989
1 reference
1 reference
6
1 reference
2
1 reference
155-162
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference